Labforward, founded in 2012, is revolutionizing the intersection of Biotechnology and Information Technology with a focus on enhancing scientific productivity. Headquartered in Germany, the company delivers software solutions that streamline laboratory workflows, aiding researchers in their quest for groundbreaking discoveries.
The company's platforms, Laboperator and Labfolder, offer comprehensive tools for experiment design, laboratory instrument control, and seamless scientific documentation. These tools not only simplify daily tasks but also enable more reliable data handling and retrieval. By connecting data, devices, and researchers, Labforward is effectively building the laboratory operating system of the future.
The firm last secured a €3.00M Series B investment on 04 May 2021 from IBB Ventures. This underscores investor confidence in their technologically innovative approach to supporting scientists worldwide. As they continue to innovate, Labforward stands poised to expand its influence in Life Sciences and Enterprise Software.